How Worried Should Investors Be About Applied Dna Sciences Inc (NASDAQ: APDN)’

Applied Dna Sciences Inc (NASDAQ:APDN) does about 27.66K shares in volume on a normal day but saw 1430995 shares change hands in Friday’s trading. The company now has a market cap of 2.97M USD. Its current market price is $3.45, marking a decrease of -7.75% compared to the previous close of $3.74. The 52 week high reached by this stock is $37.20 whilst the lowest price level in 52 weeks is $3.27.

Applied Dna Sciences Inc (APDN) has a 20-day trading average at $4.94 and the current price is -90.73% off the 52-week high compared with 5.50% distance from its 52-week low. The 50-day simple moving average of the closing price is $7.49 and its 200-day simple moving average is $16.30. If we look at the stock’s price movements over the week, volatility stands at 21.36%, which decreases to 17.37% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 20.61 to suggest the stock is oversold.

The consensus objective for the share price is $45.00, suggesting that the stock has a potential upside of 92.33% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 12, 2021 when ROTH Capital initiated the stock to “Buy” and issued a price target of $24. H.C. Wainwright reiterated its price target at $20-$12.

Applied Dna Sciences Inc (APDN) stock is down -8.00% over the week and -54.72% over the past month. Its price is -72.03% year-to-date and -84.17% over the past year.

To reach the target analysts have set, the stock logically needs to grow 92.33 percent from here.

The company has a return on investment of -2946.59% and return on equity of -246.31%. The beta has a value of 0.25. Price to sales ratio is 0.54.